CONMED (CNMD) PT Raised to $45 at Piper Sandler
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- US stocks set for higher open as AI trade steadies; midterms in focus
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops more than 4% on talks aimed at ending US-Iran war
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $44.29 --0%
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 20 | New: 16
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 20 | New: 16
Join SI Premium – FREE
Piper Sandler analyst Matt O'Brien raised the price target on CONMED (NYSE: CNMD) to $45.00 (from $39.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Procore Technologies, Inc (PCOR) PT Raised to $70; TD Cowen 'Expecting Solid Beat'
- Conmed (CNMD) Tops Q3 EPS by 4c ; Offers Guidance
- Merck (MRK) PT Raised to $155 at Cantor Fitzgerald
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
